Cooltouch Model NS 160
510(k) K040921
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK040921 | Date28 Sep 2004 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- GEX
- Device Class
- Class II
- Regulation
- 21 CFR Part 878.4810
- Advisory Committee
- General, Plastic Surgery
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 23 Sep 2026
The Cooltouch Model NS 160 is an Nd:YAG surgical laser system that emits at 1320 nm. It comprises a cabinet housing a power supply, cooling system, microcontroller, and laser source, which connects to a fiber optic delivery system.
This device is used by physicians in clinical settings for the endovenous laser treatment of greater saphenous vein reflux. Laser energy is delivered via a fiber optic to the target vein. The device is subject to FDA 510(k) authorization.
Other devices from Cooltouch, Inc.
Questions
AI-generated answers, 23 Sep 2026
What is the primary clinical application for the Cooltouch NS 160?
The Cooltouch NS 160 is specifically indicated for the endovenous laser treatment of greater saphenous vein reflux. It functions by delivering laser energy at a 1320 nm wavelength through a fiber optic delivery system directly to the target vein.
How is the laser energy delivered to the patient?
The system utilizes a fiber optic delivery system that connects to the main cabinet housing the laser source. This fiber optic component is used by the physician to transmit the 1320 nm laser energy to the site of the saphenous vein reflux.
What is the regulatory status of the Cooltouch NS 160?
The Cooltouch NS 160 is subject to FDA 510(k) authorization. It was determined to be substantially equivalent to existing devices under the K040921 submission, which was processed through a traditional clearance pathway.